Effect of Evobrutinib on Pharmacokinetics of a Combined Oral Contraceptive
Clinical trial NCT07215806 · COMPLETED
Trial details
- NCT number
- NCT07215806
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-24
- Primary completion
- 2022-11-25
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.